Literature DB >> 3181663

Esophageal candidiasis.

Y Naito1, T Yoshikawa, H Oyamada, K Tainaka, Y Morita, T Kogawa, S Sugino, M Kondo.   

Abstract

Among 3,501 individuals receiving endoscopic examination for the upper digestive tract, 41 were found to have esophageal candidiasis including 17 malignancies, 14 immunological disorders, 4 diabetes mellitus, 7 other underlying diseases and 7 apparently healthy subjects. The diagnosis was made either by brushing of the esophagus or by histological examination of the biopsied specimen. Systemic invasion of fungi was observed mainly in patients with malignancy involving the hematopoietic system, and most of them had been treated by corticosteroids, antibiotics or anticancer agents. Although complications associated with esophageal candidiasis are rare, it is emphasized that those patients with malignancy as well as impared immunity should be carefully examined for esophageal candidiasis, in order to prevent the fungi from developing invasive candidiasis. It should be noted that a few cases of gastric ulcer treated by H2 blocker revealed esophageal candidiasis, suggesting that decrease of gastric acidity might be one of the factors involved in this pathological condition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181663     DOI: 10.1007/bf02779203

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  17 in total

1.  Efficiency of serologic tests in the diagnosis of systemic candidiasis.

Authors:  P J Kozinn; C L Taschdjian; P K Goldberg; W P Protzmann; D W MacKenzie; J S Remington; S Anderson; M S Seelig
Journal:  Am J Clin Pathol       Date:  1978-12       Impact factor: 2.493

2.  Candidiasis of the oesophagus.

Authors:  P B Guyer; F J Brunton; H W Rooke
Journal:  Br J Radiol       Date:  1971-02       Impact factor: 3.039

Review 3.  Mycoses of the alimentary tract.

Authors:  J M Smith
Journal:  Gut       Date:  1969-12       Impact factor: 23.059

4.  Primary and secondary Candida esophagitis.

Authors:  K Phaosawasdi; P Rice; B Lee
Journal:  IMJ Ill Med J       Date:  1986-06

5.  Systemic candidiasis in cancer patients.

Authors:  A W Maksymiuk; S Thongprasert; R Hopfer; M Luna; V Fainstein; G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

6.  Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome.

Authors:  A Tavitian; J P Raufman; L E Rosenthal; J Weber; C A Webber; H P Dincsoy
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

7.  Esophageal, gastric, and intestinal candidiasis.

Authors:  J S Trier; D J Bjorkman
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

Review 8.  Candida esophagitis.

Authors:  R Mathieson; S K Dutta
Journal:  Dig Dis Sci       Date:  1983-04       Impact factor: 3.199

9.  Tracheoesophageal fistula: a serious complication of infectious esophagitis.

Authors:  W F Obrecht; J E Richter; G A Olympio; D W Gelfand
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

10.  Ketoconazole treatment of Candida esophagitis--a prospective study of 12 cases.

Authors:  R A Fazio; P C Wickremesinghe; E L Arsura
Journal:  Am J Gastroenterol       Date:  1983-05       Impact factor: 10.864

View more
  13 in total

1.  Esophageal Candida infection and adherence mechanisms in the nonimmunocompromised rabbit.

Authors:  K Hoshika; M Iida; H Mine
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

2.  Esophageal candidiasis in non-immune suppressed patients in a semi-urban town, southern India.

Authors:  G Badarinarayanan; R Gowrisankar; K Muthulakshmi
Journal:  Mycopathologia       Date:  2000-01       Impact factor: 2.574

3.  Candida esophagitis complicated by an esophago-airway fistula: report of a case.

Authors:  Ryu Kanzaki; Masahiko Yano; Ko Takachi; Shingo Ishiguro; Masaaki Motoori; Kentaro Kishi; Isao Miyashiro; Osamu Ishikawa; Shingi Imaoka
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

4.  Is empiric therapy with fluconazole appropriate for esophageal candidiasis?

Authors:  Kattiparambil Gangadharan Sajith; Amit Kumar Dutta; Rani Diana Sahni; Saritha Esakimuthu; Ashok Chacko
Journal:  Indian J Gastroenterol       Date:  2014-01-16

5.  Fluconazole Resistant Candida Oesophagitis in Immunocompetent Patients: Is Empirical Therapy Justifiable?

Authors:  Barnali Kakati; Aarti Kotwal; Debasis Biswas; Shantanu Sahu
Journal:  J Clin Diagn Res       Date:  2015-12-01

6.  Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients.

Authors:  Yuta Takahashi; Naoyoshi Nagata; Takuro Shimbo; Takeshi Nishijima; Koji Watanabe; Tomonori Aoki; Katsunori Sekine; Hidetaka Okubo; Kazuhiro Watanabe; Toshiyuki Sakurai; Chizu Yokoi; Masao Kobayakawa; Hirohisa Yazaki; Katsuji Teruya; Hiroyuki Gatanaga; Yoshimi Kikuchi; Sohtaro Mine; Toru Igari; Yuko Takahashi; Akio Mimori; Shinichi Oka; Junichi Akiyama; Naomi Uemura
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report.

Authors:  Kuo-Hsin Chen; Meng-Tzu Weng; Yueh-Hung Chou; Yueh-Feng Lu; Chen-Hsi Hsieh
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea.

Authors:  Jae Hyeuk Choi; Chang Geun Lee; Yun Jeong Lim; Hyoun Woo Kang; Chi Yeon Lim; Jong-Sun Choi
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

Review 9.  Oesophageal candidiasis in elderly patients: risk factors, prevention and management.

Authors:  Namal Weerasuriya; Jeremy Snape
Journal:  Drugs Aging       Date:  2008       Impact factor: 4.271

10.  The impact of systemic fungal infection in patients with perforated oesophagus.

Authors:  H Elsayed; H Shaker; I Whittle; S Hussein
Journal:  Ann R Coll Surg Engl       Date:  2012-11       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.